Pulmonx Closes Up to $60MM Credit Facility with Perceptive Advisors
Pulmonx, a global company in minimally invasive treatments for lung disease, closed a five-year credit facility for up to $60 million with Perceptive Advisors. The credit facility consists of an initial $40 million term loan drawn at closing to refinance...
Read moreDetails










